NCT05600569 Registry of the Spanish Society of Thoracic Surgery
| NCT ID | NCT05600569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sociedad Española de Cirugía Torácica |
| Condition | Pulmonary Surgical Procedures |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2032-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2023-01-01 with a primary completion date of 2032-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ReSECT is a project promoted by the Spanish Society of Thoracic Surgery with the aim not only to become an indefinite, dynamic and inclusive registry, but also to establish a common structural framework for the development of future multicentre projects in the field of thoracic surgery in Spain. The goal of this nationwide prospective observational registry is: * To develop and validate forecasting tools based on powerful computational methods with the goal of assisting in decision-making and improving quality of care. * To evaluate the progressive implementation of certain surgical techniques that are on the rise, new technologies and future health programs. * To be aware of our results as specialty and professionals and to serve as a permanent benchmarking instrument in thoracic surgery. The first part of ReSECT, based on a personal registry design, will contemplate any thoracic surgical procedure performed by thoracic surgeons and residents in thoracic surgery in our country. Additionally, the Spanish thoracic surgery departments that voluntarily accept to collectively participate will contribute to specific surgical processes focused on certain procedures with specific objectives to be progressively implemented. The first and only surgical process implemented since the start of the ReSECT project will focus on patients to undergo anatomical lung resection with special interest in those cases whose reason for intervention was lung cancer. The main questions to answer in case of that first surgical process include: * What is the performance of current predictive models for perioperative and oncological outcomes in our country? * How could we modify previous predictive models to improve their performance? * What is the implementation of current guideline recommendations in our country and across institutions? * What is the potential impact of deviations from current recommendations? * What is my performance compared to the rest of the thoracic surgical departments in my country in terms of perioperative and oncological outcomes? ReSECT does not consider prespecified comparison groups of patients.
Eligibility Criteria
The inclusion criteria will depend on the section of the registry to be considered. * Personal registry: patients undergoing any type of surgical intervention. * Registry of surgical processes by departments: patients undergoing an anatomical pulmonary resection as the first process to be implemented at the time ReSECT is to be established. Exclusion Criteria: * Patients who could reject to participate in this study.
Contact & Investigator
Raúl Embún, PhD
STUDY DIRECTOR
Hospital Universitario Miguel Servet / raulembun@gmail.com / Phone: +34 635 492179
Frequently Asked Questions
Who can join the NCT05600569 clinical trial?
This trial is open to participants of all sexes, studying Pulmonary Surgical Procedures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05600569 currently recruiting?
Yes, NCT05600569 is actively recruiting participants. Contact the research team at dgavm@yahoo.es for enrollment information.
Where is the NCT05600569 trial being conducted?
This trial is being conducted at Zaragoza, Spain.
Who is sponsoring the NCT05600569 clinical trial?
NCT05600569 is sponsored by Sociedad Española de Cirugía Torácica. The principal investigator is Raúl Embún, PhD at Hospital Universitario Miguel Servet / raulembun@gmail.com / Phone: +34 635 492179. The trial plans to enroll 30,000 participants.